Cancer therapy-induced cardiotoxicity: Basic mechanisms and potential cardioprotective therapies

245Citations
Citations of this article
278Readers
Mendeley users who have this article in their library.

Abstract

Mechanisms of cancer therapy-induced cardiotoxicity include a combination of on-target effects on signaling cascades essential to both cancer progression and normal cardiac function and off-target effects due to nonselective actions. Effective therapies to treat cancer and cancer therapy- induced cardiotoxicity must either take advantage of tissuespecific differences or affect the downstream mediators of toxicity, and there are active studies under way to develop new targeted therapies.140,141 Other effective therapies for cardioprotection include typical pharmacologic therapies used in cardiovascular disease that promote increased cardiac reserve and reverse remodeling under the stress of cancer therapy. Most of the data regarding mechanisms of cardiotoxicity due to cancer therapy have been obtained from animal models of this disease process; therefore, further studies to improve our understanding of the relevance of these pathways in humans are necessary. © 2014 The Authors.

Cite

CITATION STYLE

APA

Hahn, V. S., Lenihan, D. J., & Ky, B. (2014). Cancer therapy-induced cardiotoxicity: Basic mechanisms and potential cardioprotective therapies. Journal of the American Heart Association. John Wiley and Sons Inc. https://doi.org/10.1161/JAHA.113.000665

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free